Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms

Completed

Conditions studied: Chronic Pancreatitis

In brief

Exocrine Pancreatic Insufficiency (EPI) is a condition where pancreatic enzyme quantity or activity is reduced below threshold needed for normal digestion. Symptoms include bloating, flatulence, diarrhea and steatorrhea. This is an observational study assessing for effect of CREON on symptoms of EPI in participants with EPI due to chronic pancreatitis.

Key facts

Study ID

NCT04949828

Run by

AbbVie

People needed

63

Starts

2021-09-16

Expected to finish

2024-02-29

Last updated by the study team

2024-03-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Medical history of chronic pancreatitis (CP).
• Diagnosis of Exocrine Pancreatic Insufficiency (EPI).

You may not qualify if…

• -History of cystic fibrosis, pancreatic cancer, pancreatic surgery, gastric bypass surgery, extensive bowel surgery, inflammatory bowel disease, celiac disease, irritable bowel syndrome

Where it is running

• Stanford University School of Med /ID# 229530 — Stanford, California, United States
• University of Florida - Archer /ID# 227057 — Gainesville, Florida, United States
• John Hopkins University /ID# 227061 — Baltimore, Maryland, United States
• NYU Langone Health /ID# 230818 — New York, New York, United States
• The Ohio State University Wexner Medical Center /ID# 227844 — Columbus, Ohio, United States
• Baylor College of Medicine - Baylor Medical Center /ID# 227067 — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.